摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl 5-triflatonicotinate | 342024-50-4

中文名称
——
中文别名
——
英文名称
methyl 5-triflatonicotinate
英文别名
methyl 5-(((trifluoromethyl)sulfonyl)oxy)nicotinate;methyl 5-trifluoromethanesulfonyloxy-3-pyridinecarboxylate;methyl 5-(trifluoromethylsulfonyloxy)pyridine-3-carboxylate
methyl 5-triflatonicotinate化学式
CAS
342024-50-4
化学式
C8H6F3NO5S
mdl
——
分子量
285.201
InChiKey
FELGUHIBRAXSOO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    334.0±42.0 °C(Predicted)
  • 密度:
    1.567±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    18
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    90.9
  • 氢给体数:
    0
  • 氢受体数:
    9

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    methyl 5-triflatonicotinate 在 C94H134O4P2Pd2 、 cesium fluoride 作用下, 以 甲苯 为溶剂, 反应 14.0h, 以44%的产率得到5-氟吡啶-3-甲酸甲酯
    参考文献:
    名称:
    An Improved Catalyst System for the Pd-Catalyzed Fluorination of (Hetero)Aryl Triflates
    摘要:
    The stable Pd(0) species [(1,5-cyclooctadiene)(L.Pd)(2)] (L = AdBrettPhos) has been prepared and successfully evaluated as a precatalyst for the fluorination of aryl triflates derived from biologically active and heteroaryl phenols, challenging substrates for our previously reported catalyst system. Additionally, this precatalyst activates at room temperature under neutral conditions, generates 1,5-cyclooctadiene as the only byproduct, and leads to overall cleaner reaction profiles.
    DOI:
    10.1021/ol402859k
  • 作为产物:
    参考文献:
    名称:
    An Improved Catalyst System for the Pd-Catalyzed Fluorination of (Hetero)Aryl Triflates
    摘要:
    The stable Pd(0) species [(1,5-cyclooctadiene)(L.Pd)(2)] (L = AdBrettPhos) has been prepared and successfully evaluated as a precatalyst for the fluorination of aryl triflates derived from biologically active and heteroaryl phenols, challenging substrates for our previously reported catalyst system. Additionally, this precatalyst activates at room temperature under neutral conditions, generates 1,5-cyclooctadiene as the only byproduct, and leads to overall cleaner reaction profiles.
    DOI:
    10.1021/ol402859k
点击查看最新优质反应信息

文献信息

  • A General, Multimetallic Cross-Ullmann Biheteroaryl Synthesis from Heteroaryl Halides and Heteroaryl Triflates
    作者:Kai Kang、Nathan L. Loud、Tarah A. DiBenedetto、Daniel J. Weix
    DOI:10.1021/jacs.1c10907
    日期:2021.12.29
    medicine and materials science, the synthesis of biheteroaryls by cross-coupling remains challenging. We describe here a new, general approach to biheteroaryls: the Ni- and Pd-catalyzed multimetallic cross-Ullmann coupling of heteroaryl halides with triflates. An array of 5-membered, 6-membered, and fused heteroaryl bromides and chlorides, as well as aryl triflates derived from heterocyclic phenols,
    尽管它们对医学和材料科学很重要,但通过交叉偶联合成双杂芳基仍然具有挑战性。我们在这里描述了一种新的、通用的双杂芳基方法:杂芳基卤化物与三氟甲磺酸酯的 Ni 和 Pd 催化的多金属交叉 Ullmann 偶联。一系列 5 元、6 元和稠合杂芳基溴化物和氯化物,以及衍生自杂环酚的芳基三氟甲磺酸酯,被证明是该反应中可行的底物(62 个示例,平均产率为 63 ± 17%)。这种方法对双杂芳基的普遍性在 10 μmol 规模的 96 孔板格式中得到进一步证明。一组 96 种可能的产品在一组条件下提供了 >90% 的命中率。此外,可以使用配体、添加剂和还原剂的单个“工具箱板”快速优化低产率组合。
  • 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity
    申请人:Takeda Pharmaceutical Company Limited
    公开号:US07179823B1
    公开(公告)日:2007-02-20
    A compound of formula (I) F wherein R1 represents a hydrocarbon group which may be substituted or a heterocyclic group which may be substituted; x represents a bond, an oxygen atom, a sulfur atom, or a group of the formula: —CO—, —CS—, —CR4(OR5)— or —NR6— wherein each of R4 and R6 represents a hydrogen atom or a hydrocarbon group which may be stubstituted, R5 represents a hydrogen atom or a protective group for a hydroxyl group; m represents an integer of 0 to 3; Y represents an oxygen atom, a sulfur atom, or a group of the formula: —SO—, —SO2—, —NR7—, —CONR7— or —NR7CO— wherein R7 represents a hydrogen atom or a hydrocarbon group which may be substituted; ring A represents an aromatic ring which may further have 1 to 3 substituents; n represents an integer of 1 to 8; ring B represents a nitrogen-containing 5-membered hetero ring which may further be substituted by an alkyl group.
    化合物的式子为(I)F,其中R1代表一个可以被取代的碳氢基团或杂环基团;x代表一个键、一个氧原子、一个硫原子或者一个式子为:—CO—、—CS—、—CR4(OR5)—或—NR6—的基团,其中R4和R6分别代表一个氢原子或者一个可以被取代的碳氢基团,R5代表一个氢原子或者一个羟基的保护基团;m代表一个0到3的整数;Y代表一个氧原子、一个硫原子或者一个式子为:—SO—、—SO2—、—NR7—、—CONR7—或—NR7CO—的基团,其中R7代表一个氢原子或者一个可以被取代的碳氢基团;环A代表一个芳香环,可以有1到3个取代基;n代表一个1到8的整数;环B代表一个含氮的5元杂环,可以有一个烷基的取代基。
  • 5-membered N-heterocyclic compounds with hypoglycemic and hypolipidemic activity
    申请人:Takeda Chemical Industries, Ltd.
    公开号:EP1457490A1
    公开(公告)日:2004-09-15
    Use of a compound of the formula: wherein R1 represents a hydrocarbon group which may be substituted or a heterocyclic group which may be substituted; X represents a bond, an oxygen atom, a sulfur atom, or a group of the formula: -CO-, -CS-, -CR4(OR5)- or -NR6- wherein each of R4 and R6 represents a hydrogen atom or a hydrocarbon group which may be substituted, R5 represents a hydrogen atom or a protective group for a hydroxyl group; m represents an integer of 0 to 3; Y represents an oxygen atom, a sulfur atom, or a group of the formula: -SO-, -SO2-, -NR7-, -CONR7- or -NR7CO- wherein R7 represents a hydrogen atom or a hydrocarbon group which may be substituted; ring A represents an aromatic ring which may further have 1 to 3 substituents; n represents an integer of 1 to 8; ring B represents a nitrogen-containing 5-membered hetero ring which may further be substituted by an alkyl group; X1 represents a bond, an oxygen atom, a sulfur atom, or a group of the formula: -SO-, -SO2-, -O-SO2- or -NR16- wherein R16 represents a hydrogen atom or a hydrocarbon group which may be substituted; R2 represents a hydrogen atom, a hydrocarbon group which may be substituted or a heterocyclic group which may be substituted; W represents a bond or a divalent hydrocarbon residue having 1 to 20 carbon atoms; R3 represents a group of the formula: -OR8 (R8 represents a hydrogen atom or a hydrocarbon group which may be substituted) or -NR9R10 (each of R9 and R10, whether identical or not, represents a hydrogen atom, a hydrocarbon group which may be substituted, a heterocyclic group which may be substituted, or an acyl group which may be substituted; R9 and R10 may bind together to form a ring); or a salt thereof, for the manufacture of a pharmaceutical preparation for preventing or treating syndrome X.
    式化合物的用途: 其中 R1 代表可被取代的烃基或可被取代的杂环基; X 代表键、氧原子、硫原子或式中的基团:-其中 R4 和 R6 分别代表氢原子或可被取代的烃基,R5 代表氢原子或羟基的保护基团; m 代表 0 至 3 的整数; Y 代表氧原子、硫原子或式中的一个基团:-其中 R7 代表氢原子或可被取代的烃基; 环 A 代表芳香环,可进一步具有 1 至 3 个取代基; n 代表 1 至 8 的整数; 环 B 代表含氮 5 元杂环,可进一步被烷基取代; X1 代表键、氧原子、硫原子或式中的基团:-其中 R16 代表氢原子或可被取代的烃基; R2 代表氢原子、可被取代的烃基或可被取代的杂环基; W 代表键或具有 1 至 20 个碳原子的二价烃残基; R3 代表式中的一个基团:-OR8(R8代表氢原子或可被取代的烃基)或-NR9R10(R9和R10,无论是否相同,各自代表氢原子、可被取代的烃基、可被取代的杂环基或可被取代的酰基;R9和R10可结合在一起形成环);或其盐、 用于制造预防或治疗 X 综合征的药物制剂。
  • 5-MEMBERED N-HETEROCYCLIC COMPOUNDS WITH HYPOGLYCEMIC AND HYPOLIPIDEMIC ACTIVITY
    申请人:Takeda Chemical Industries, Ltd.
    公开号:EP1228067B1
    公开(公告)日:2004-07-14
  • 5-MEMBERED N-HETEROCYCLIC COMPOUNDS WITH HYPOGYLCEMIC AND HYPOLIPIDEMIC ACTIVITY
    申请人:Takeda Chemical Industries, Ltd.
    公开号:EP1228067A1
    公开(公告)日:2002-08-07
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-